KAPPADIONE Drug Patent Profile
✉ Email this page to a colleague
When do Kappadione patents expire, and what generic alternatives are available?
Kappadione is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in KAPPADIONE is menadiol sodium diphosphate. There is one drug master file entry for this compound. Additional details are available on the menadiol sodium diphosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KAPPADIONE?
- What are the global sales for KAPPADIONE?
- What is Average Wholesale Price for KAPPADIONE?
Summary for KAPPADIONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Patent Applications: | 26 |
| DailyMed Link: | KAPPADIONE at DailyMed |
US Patents and Regulatory Information for KAPPADIONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | KAPPADIONE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 005725-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
